Strong Xtandi Drives Astellas To Brighter Outlook

 
• By Ian Haydock

Japanese firm unveils new capital investment program for novel biologics including antibodies and cell therapies as it ups full-year forecasts on strong US and global growth for Xtandi after a solid first half.

currency
Strong US Xtandi Performance Boosts Astellas • Source: Shutterstock

More from Business

More from Scrip